New platform optimizes selection of combination cancer therapies: Bioinformatics approach predicts combinations with improved outcomes in pre-clinical and clinical studies

Researchers have developed a new computational tool to select optimal combination therapies for patients with cancer based on the co-occurring alterations in a given tumor.

Leave a Comment